GLP-1 Access by StateSD

GLP-1 Weight Loss Medications in South Dakota

Access GLP-1 medications in South Dakota through telehealth, Medicaid, and regional health systems.

Telehealth Prescribing

Allowed

Restrictions

South Dakota has permanent telehealth access provisions. The state participates in the Interstate Medical Licensure Compact. Providers must be licensed in South Dakota or hold compact licensure. No originating-site restrictions. Broadband access can be limited in western SD and reservation communities.

Prescribing Rules

GLP-1 medications can be prescribed via telehealth without a prior in-person visit. South Dakota does not impose additional prescribing restrictions on non-controlled substances beyond federal requirements. NPs have independent prescriptive authority.

Insurance Coverage

Medicaid Coverage

Yes (expanded)

Prior Authorization

Typically required

Major Insurers

Sanford Health PlanAvera Health PlansDakotaCareWellmark Blue Cross Blue Shield

South Dakota voters approved Medicaid expansion via Amendment D in November 2022, with coverage effective July 2023. SD Medicaid covers GLP-1s for diabetes. The commercial market is dominated by Sanford Health Plan and Avera Health Plans, both integrated with the state's two largest health systems.

Cost Breakdown

Brand Name

$900-$1300

per month, without insurance

Compounded

Available

$150-$400

per month

Top Providers in South Dakota

Sanford Health Weight Management

Both

Sioux Falls-based system with comprehensive obesity medicine; dominant health system in the Dakotas.

Avera Health - Medical Weight Management

Both

Sioux Falls-based system with weight management services across eastern South Dakota.

Found

Telehealth

Telehealth weight loss platform serving all SD ZIP codes with board-certified providers.

Medicaid Expansion via Voter Initiative

South Dakota voters approved Medicaid expansion through Amendment D in November 2022, with coverage beginning July 2023. This extended Medicaid eligibility to adults earning up to 138% of the federal poverty level. The expansion was significant for GLP-1 access, as newly eligible adults with type 2 diabetes can now access covered GLP-1 therapy. Approximately 50,000 additional South Dakotans gained coverage.

The Two-System Landscape: Sanford and Avera

South Dakota healthcare is largely a two-system market. Sanford Health and Avera Health together operate the vast majority of hospitals, clinics, and insurance products in the state. Both systems have weight management programs that include GLP-1 prescribing. Sanford, being the larger system with reach into North Dakota and Minnesota, has a more extensive telehealth infrastructure. Avera serves primarily eastern South Dakota and portions of surrounding states.

Tribal Health and IHS Access

South Dakota has nine tribal reservations, including the Pine Ridge, Rosebud, and Cheyenne River Sioux reservations. IHS facilities serve these communities, but historically face funding and supply constraints. GLP-1 availability through IHS varies by facility. The Great Plains Area IHS has been working to expand metabolic health services. Tribal members may also access state Medicaid coverage under expansion.

IHS formulary may include GLP-1 medications at some facilities
Tribal health programs have independent prescribing authority
Medicaid expansion provides dual eligibility for some tribal members
Telehealth can supplement in-person IHS visits for ongoing management

Rural and Western SD Access

Western South Dakota, particularly the Black Hills region and areas west of the Missouri River, has limited healthcare access. Rapid City is the only significant medical center west of the river. Telehealth is critical for western SD residents seeking GLP-1 access. Monument Health (Rapid City) and IHS facilities are the primary in-person options. Broadband limitations on reservations and in remote ranch communities can affect telehealth quality.

FAQ

Frequently Asked Questions

Yes. South Dakota allows telehealth prescribing of GLP-1 medications through video consultation without a prior in-person visit.

Yes. Following voter-approved Medicaid expansion effective July 2023, SD Medicaid covers GLP-1 medications for type 2 diabetes with prior authorization.

GLP-1 availability through IHS varies by facility. Contact your local IHS or tribal health center for current formulary information. Telehealth can supplement IHS care.

Brand-name GLP-1s cost $900-$1,300/month. Compounded semaglutide is available for $150-$400/month through telehealth platforms that deliver to all SD addresses.